Literature DB >> 28176030

Endoscopic approach to the upper cervical spine and clivus: an anatomical study of the upper limits of the transoral corridor.

Emanuele La Corte1,2, Philipp R Aldana3.   

Abstract

BACKGROUND: Recent advances in endoscopic techniques have allowed minimally invasive approaches to the cranio-vertebral junction (CVJ) through the oropharynx (ETA) in addition to the transnasal approach (EEA). These minimally invasive endoscopic techniques allow for increased surgical exposure using no visible incisions, with a potential less morbidity. The ability to know preoperatively the limit of the ETA is vital for the surgical planning in order to better address CVJ pathology. The aim of the present study is to determine the anatomical limits of endoscopic dissection of the skull base and upper cervical spine through the transoral corridor and the superior limit reached by adopting this approach.
METHODS: Six fresh-frozen adult cadaver heads were dissected adopting ETA preserving the hard and soft palate. The most superior extent of the exposure was dissected. Post-operative CT scans were performed to confirm the superior extent.
RESULTS: The superior most limit of dissection corresponded to the sphenoid-occipital junction, where the basilar portion of the occipital bone joins with the sphenoid bone's body. This ranged from 12.7 to 18.9 mm above the line of the hard palate. This was achieved without having to transgress any of the palatine structures.
CONCLUSIONS: The sphenoid-occipital junction represents the rostral limit of endoscopic transoral approach to the lower skull base and CVJ area. This approach is limited superiorly by the orientation of the hard palate and mouth aperture and lower dentition due to the linear nature of the endoscope. Using the endoscope for this approach can allow for a more superior exposure than the traditional open transoral approach.

Entities:  

Keywords:  Clivus; Craniovertebral junction; Endoscopy; Minimally invasive spine surgery; Odontoidectomy; Skull base surgery; Transoral approach

Mesh:

Year:  2017        PMID: 28176030     DOI: 10.1007/s00701-017-3103-6

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  5 in total

1.  Peri-operative prognostic factors for primary skull base chordomas: results from a single-center cohort.

Authors:  Emanuele La Corte; Morgan Broggi; Alberto Raggi; Silvia Schiavolin; Francesco Acerbi; Giovanni Danesi; Mariangela Farinotti; Giovanni Felisati; Alberto Maccari; Bianca Pollo; Marco Saini; Claudia Toppo; Francesca Valvo; Riccardo Ghidoni; Maria Grazia Bruzzone; Francesco DiMeco; Paolo Ferroli
Journal:  Acta Neurochir (Wien)       Date:  2020-01-16       Impact factor: 2.216

2.  Long and Very-Long-Chain Ceramides Correlate with A More Aggressive Behavior in Skull Base Chordoma Patients.

Authors:  Emanuele La Corte; Michele Dei Cas; Alberto Raggi; Monica Patanè; Morgan Broggi; Silvia Schiavolin; Chiara Calatozzolo; Bianca Pollo; Carlotta Pipolo; Maria Grazia Bruzzone; Giuseppe Campisi; Rita Paroni; Riccardo Ghidoni; Paolo Ferroli
Journal:  Int J Mol Sci       Date:  2019-09-11       Impact factor: 5.923

3.  Reconsideration of the transoral odontoidectomy in complex craniovertebral junction patients with irreducible anterior compression.

Authors:  Xingwen Wang; Longbing Ma; Zhenlei Liu; Zan Chen; Hao Wu; Fengzeng Jian
Journal:  Chin Neurosurg J       Date:  2020-09-15

4.  Volumetric comparative analysis of anatomy through far-lateral approach: surgical space and exposed tissues.

Authors:  Ke Tang; Xu Feng; Yang Li
Journal:  Chin Neurosurg J       Date:  2022-01-10

5.  Transnasal Endoscopic and Transoral Approaches in the Biopsies of Ventral Atlas and Axis Vertebrae: A Comprehensive Retrospective Study for Preprocedural Scheme, Biopsy Procedure, Core Technique Analysis, Diagnostic Yield and Clinical Outcome.

Authors:  Xianhao Shao; Jianmin Li; Qiang Yang; Ka Li; Yuan Yao; Feifei Sun; Zhenfeng Li
Journal:  Orthop Surg       Date:  2022-06-15       Impact factor: 2.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.